• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结肠憩室病的新兴疗法。

Emerging therapies for diverticular disease of the colon.

作者信息

Trivedi Chirag D, Das Kiron M

机构信息

Division of Gastroenterology, Department of Medicine, Crohn's and Colitis Center of New Jersey, New Brunswick, NJ 08903, USA.

出版信息

J Clin Gastroenterol. 2008 Nov-Dec;42(10):1145-51. doi: 10.1097/MCG.0b013e318188adc1.

DOI:10.1097/MCG.0b013e318188adc1
PMID:18936655
Abstract

Diverticular disease (DD) of the colon is common. This paper reviews the evidence supporting the role of some of the conventional medical therapies such as fiber and nonabsorbable antibiotics in the treatment of DD. More importantly, it will review the emerging body of evidence supporting the use of 5-aminosalicylic acid and probiotics for symptomatic or complicated DD. Possible mechanisms supporting the role of 5-aminosalicylates will also be discussed. On the basis of strength of the evidence supporting each medical intervention, recommendations will be graded in an evidence-based fashion. Finally, an evidence-based algorithmic approach is proposed for the medical management of DD. This paper does not discuss the use of absorbable antibiotics such as ciprofloxin and metronidazole, which are discussed in all standard textbooks. The purpose of this paper is to discuss newer recommendations.

摘要

结肠憩室病(DD)很常见。本文回顾了支持一些传统医学疗法(如纤维和不可吸收抗生素)在DD治疗中作用的证据。更重要的是,它将回顾支持使用5-氨基水杨酸和益生菌治疗有症状或复杂DD的新证据。还将讨论支持5-氨基水杨酸盐作用的可能机制。根据支持每种医学干预措施的证据强度,将以循证方式对建议进行分级。最后,提出了一种基于循证的算法方法用于DD的药物治疗。本文不讨论可吸收抗生素(如环丙沙星和甲硝唑)的使用,所有标准教科书中都有相关论述。本文的目的是讨论更新的建议。

相似文献

1
Emerging therapies for diverticular disease of the colon.结肠憩室病的新兴疗法。
J Clin Gastroenterol. 2008 Nov-Dec;42(10):1145-51. doi: 10.1097/MCG.0b013e318188adc1.
2
Treatment options for uncomplicated diverticular disease of the colon.结直肠单纯性憩室病的治疗选择。
J Clin Gastroenterol. 2009 Oct;43(9):803-8. doi: 10.1097/MCG.0b013e3181b3ab2e.
3
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.综述文章:结肠憩室病和憩室炎的病理生理学和医学治疗。
Aliment Pharmacol Ther. 2015 Sep;42(6):664-84. doi: 10.1111/apt.13322. Epub 2015 Jul 22.
4
Management of diverticulosis: what's new?憩室病的管理:有哪些新进展?
Minerva Med. 2017 Oct;108(5):448-463. doi: 10.23736/S0026-4806.17.05201-6. Epub 2017 May 2.
5
Advances in the management of colonic diverticulitis.结肠憩室炎管理的进展
CMAJ. 2012 Sep 18;184(13):1470-6. doi: 10.1503/cmaj.120580. Epub 2012 Aug 27.
6
Aminosalicylates.氨基水杨酸类。
Dig Dis. 2012;30(1):92-9. doi: 10.1159/000335906. Epub 2012 May 3.
7
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.有症状的非复杂性结肠憩室病的病理生理学与治疗策略
Dig Dis Sci. 2016 Mar;61(3):673-83. doi: 10.1007/s10620-015-3925-0. Epub 2015 Oct 12.
8
Acute diverticulitis of the colon--current medical therapeutic management.结肠急性憩室炎——当前的医学治疗管理
Expert Opin Pharmacother. 2004 Jan;5(1):55-9. doi: 10.1517/14656566.5.1.55.
9
Use of mesalazine in diverticular disease.美沙拉嗪在憩室病中的应用。
J Clin Gastroenterol. 2006 Aug;40 Suppl 3:S155-9. doi: 10.1097/01.mcg.0000225509.98041.4b.
10
New physiopathological and therapeutic approaches to diverticular disease: an update.憩室病的新病理生理学和治疗方法:最新进展
Expert Opin Pharmacother. 2014 May;15(7):1005-17. doi: 10.1517/14656566.2014.903922. Epub 2014 Mar 31.

引用本文的文献

1
Investigating the causal links among gut microbiome features, inflammation-related proteins, and diverticular disease: Insights from a mediation Mendelian randomization study.探究肠道微生物群特征、炎症相关蛋白与憩室病之间的因果关系:中介孟德尔随机化研究的见解
Medicine (Baltimore). 2025 May 30;104(22):e42676. doi: 10.1097/MD.0000000000042676.
2
Use of rifaximin in gastrointestinal and liver diseases.利福昔明在胃肠道和肝脏疾病中的应用。
World J Gastroenterol. 2016 Aug 7;22(29):6638-51. doi: 10.3748/wjg.v22.i29.6638.
3
Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease.
评估利福昔明治疗单纯性憩室病疗效和耐受性的非干预性研究。
Wien Klin Wochenschr. 2014 Jan;126(1-2):9-14. doi: 10.1007/s00508-013-0447-7. Epub 2013 Nov 16.
4
New strategies for the management of diverticular disease: insights for the clinician.治疗憩室病的新策略:临床医生的新视角。
Therap Adv Gastroenterol. 2013 May;6(3):205-13. doi: 10.1177/1756283X13478679.
5
Features and management of colonic diverticular disease.结肠憩室病的特征与管理
Curr Gastroenterol Rep. 2010 Oct;12(5):399-407. doi: 10.1007/s11894-010-0126-z.
6
Epidemiology and pathophysiology of diverticular disease.憩室病的流行病学与病理生理学
Clin Colon Rectal Surg. 2009 Aug;22(3):141-6. doi: 10.1055/s-0029-1236157.